Heukamp LC - Search Results

1

Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.

Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, VON Ruecker A, Müller SC, Bastian PJ. Hauser S, et al. Among authors: heukamp lc. Anticancer Res. 2010 Jul;30(7):2785-9. Anticancer Res. 2010. PMID: 20683013

2

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.

Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ. Ellinger J, et al. Among authors: heukamp lc. Prostate. 2008 Jan 1;68(1):42-9. doi: 10.1002/pros.20651. Prostate. 2008. PMID: 18004747

3

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ. Ellinger J, et al. Among authors: heukamp lc. J Urol. 2008 Jan;179(1):346-52. doi: 10.1016/j.juro.2007.08.091. Epub 2007 Nov 19. J Urol. 2008. PMID: 18006010

4

Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.

Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G. Ellinger J, et al. Among authors: heukamp lc. Urol Oncol. 2012 Jul-Aug;30(4):509-15. doi: 10.1016/j.urolonc.2010.03.004. Epub 2010 Sep 26. Urol Oncol. 2012. PMID: 20870429

5

Circulating microRNAs (miRNA) in serum of patients with prostate cancer.

Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J. Mahn R, et al. Among authors: heukamp lc. Urology. 2011 May;77(5):1265.e9-16. doi: 10.1016/j.urology.2011.01.020. Urology. 2011. PMID: 21539977

6

Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.

Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A. Bastian PJ, et al. Among authors: heukamp lc. Clin Cancer Res. 2005 Jun 1;11(11):4097-106. doi: 10.1158/1078-0432.CCR-04-1832. Clin Cancer Res. 2005. PMID: 15930345

7

Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.

Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A. Bastian PJ, et al. Among authors: heukamp lc. Eur Urol. 2007 Mar;51(3):665-74; discussion 674. doi: 10.1016/j.eururo.2006.08.008. Epub 2006 Aug 23. Eur Urol. 2007. PMID: 16956712

8

Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.

Ellinger J, Bastian PJ, Haan KI, Heukamp LC, Buettner R, Fimmers R, Mueller SC, von Ruecker A. Ellinger J, et al. Among authors: heukamp lc. Int J Cancer. 2008 Jan 1;122(1):138-43. doi: 10.1002/ijc.23057. Int J Cancer. 2008. PMID: 17764114

9

CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.

Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A. Ellinger J, et al. Among authors: heukamp lc. Urology. 2008 Jan;71(1):161-7. doi: 10.1016/j.urology.2007.09.056. Urology. 2008. PMID: 18242387

10

Global levels of histone modifications predict prostate cancer recurrence.

Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, von Ruecker A. Ellinger J, et al. Among authors: heukamp lc. Prostate. 2010 Jan 1;70(1):61-9. doi: 10.1002/pros.21038. Prostate. 2010. PMID: 19739128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters